Balchem (BCPC) Cash & Equivalents (2010 - 2026)

Balchem (BCPC) has 17 years of Cash & Equivalents data on file, last reported at $72.9 million in Q1 2026.

• Cash & Equivalents for Q1 2026 came in at $72.9 million, up 46.04% year-over-year; the trailing twelve-month figure through Mar 2026 was $72.9 million (up 46.04% YoY), and the FY2025 annual result was $74.6 million, up 50.6% from the prior year.
• Cash & Equivalents fell to $72.9 million in Q1 2026 per BCPC's latest filing, from $74.6 million in the prior quarter.
• Over five years, Cash & Equivalents peaked at $77.0 million in Q3 2023 and troughed at $49.5 million in Q4 2024.
• A 5-year average of $65.1 million and a median of $65.1 million in 2025 frame the typical range for Cash & Equivalents.
• The sharpest annual moves came in 2022 and 2025: Cash & Equivalents tumbled 37.24% in 2022, then soared 50.6% in 2025.
• A 5-year view of Cash & Equivalents shows it stood at $66.6 million in 2022, then fell by 3.17% to $64.4 million in 2023, then declined by 23.17% to $49.5 million in 2024, then soared by 50.6% to $74.6 million in 2025, then dropped by 2.28% to $72.9 million in 2026.
• Business Quant data shows BCPC's Cash & Equivalents at $72.9 million in Q1 2026, $74.6 million in Q4 2025, and $65.1 million in Q3 2025.